Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma

NCT07269535 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT07269535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07269535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Validation Study of Radiomics in the Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma
Lead sponsor
Tongji Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
January 1, 2050
Enrollment
500 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ai (artificial intelligence), mri, prospective observational study, radiomic, uterine fibroid, uterine sarcoma